NCT00005975View on ClinicalTrials.gov

S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

September 30, 2001

Study Completion Date

March 31, 2002

Conditions
Breast CancerHot Flashes
Interventions
DRUG

Megestrol Acetate 20mg/day

Double blinded Megestrol Acetate 20 mg/day

DRUG

Megestrol Acetate 40 mg/day

Double blinded Megestrol Acetate 40 mg/day

DRUG

Megestrol Acetate Placebo 20 mg/day

Megestrol Acetate Placebo 20 mg/day

DRUG

Megestrol Acetate Placebo 40 mg/day

Megestrol Acetate Placebo 40 mg/day

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

SWOG Cancer Research Network

NETWORK

NCT00005975 - S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer | Biotech Hunter | Biotech Hunter